Basic Information
MONOFER® SOLUTION FOR INJECTION OR INFUSION 100 MG/ML
INJECTION, SOLUTION
Regulatory Information
SIN15855P
November 14, 2019
Prescription Only
Therapeutic
INTRAVENOUS DRIP, INTRAVENOUS BOLUS
August 10, 2023
June 3, 2025
XB03AC
Company Information
Active Ingredients
Strength: 100 mg/ml
Detailed Information
Contraindications
**4.3 Contraindications** - Hypersensitivity to the active substance, to Monofer or any of the excipients - Known serious hypersensitivity to other parental iron products - Non-iron deficiency anaemia (eg. haemolytic anaemia) - Iron overload or disturbances in utilisation of iron (Eg. haemochromatosis, haemosiderosis) - Decompensated liver cirrhosis or active hepatitis
Indication Information
**4.1 Therapeutic indications** Monofer is indicated for the treatment of iron deficiency in adults, under the following conditions: - When oral iron preparations are ineffective or cannot be used - Where there is a clinical need to deliver iron rapidly The diagnosis must be based on laboratory tests.